A newly filed putative class action in the Northern District of California takes aim at supplement maker Pharmavite LLC, placing the company’s marketing and labeling practices under the microscope. In Spencer et al v. Pharmavite LLC, filed May 29, 2026, the named plaintiffs appear to be pursuing claims on behalf of consumers who purchased Pharmavite products allegedly marketed in a misleading manner.

While the complaint will provide the precise contours of the proposed class, cases like this typically define the class as purchasers of the challenged products during a specified limitations period, often on a statewide or nationwide basis depending on the claims asserted.